What Percent Of Antibiotics Are Given To Animals Fda
Public Health Rep. 2012 January-Feb; 127(1): 4–22.
A Review of Antibiotic Utilise in Food Animals: Perspective, Policy, and Potential
Timothy F. Landers
aThe Ohio Country University, Higher of Nursing, Columbus, OH
Bevin Cohen
bHeart for Interdisciplinary Research to Reduce Antibiotic Resistance, Columbia University School of Nursing, New York, NY
Thomas E. Wittum
cThe Ohio State Academy, Department of Veterinary Preventive Medicine, Columbus, OH
Elaine L. Larson
bCentre for Interdisciplinary Research to Reduce Antibiotic Resistance, Columbia University School of Nursing, New York, NY
SYNOPSIS
Antibiotic use plays a major role in the emerging public health crisis of antibiotic resistance. Although the majority of antibody use occurs in agricultural settings, relatively petty attending has been paid to how antibiotic use in subcontract animals contributes to the overall trouble of antibiotic resistance. The aim of this review is to summarize literature on the function of antibiotics in the development of resistance and its risk to man health. We searched multiple databases to identify major lines of argument supporting the part of agronomical antibiotic apply in the evolution of resistance and to summarize existing regulatory and policy documents. Several lines of reasoning support the determination that agricultural antibiotics are associated with resistance, even so most public policy is based on expert opinion and consensus. Finally, we propose strategies to address current gaps in knowledge.
Antibiotic resistance is a looming public wellness crunch. While once believed to be the province of hospitals and other health-care facilities, a host of customs factors are now known to promote antibiotic resistance, and community-associated resistant strains have now been implicated as the cause of many hospital-acquired infections.1 , 2 An inherent issue of exposure to antibiotic compounds, antibody resistance arises as a result of natural choice.iii Due to normal genetic variation in bacterial populations, individual organisms may comport mutations that render antibiotics ineffective, conveying a survival reward to the mutated strain. In the presence of antibiotics, advantageous mutations tin besides be transferred via plasmid exchange inside the bacterial colony, resulting in proliferation of the resistance trait.iv The emergence of drug resistance has been observed following the introduction of each new class of antibiotics, and the threat is compounded past a deadening drug development pipeline and limited investment in the discovery and evolution of new antibody agents.five – 7
International, national, and local antibiotic stewardship campaigns have been adult to encourage prudent use of and limit unnecessary exposure to antibiotics, with the ultimate goal of preserving their effectiveness for serious and life-threatening infections.8 , nine In do, still, clinicians must residual the utilitarian goal of preserving the effectiveness of antibiotics with upstanding obligations to patients who nowadays with conditions that are unlikely to be harmed and may do good from antibiotic apply. There is besides considerable debate in veterinarian medicine regarding use of antibiotics in animals raised for homo consumption (food animals). The potential threat to human health resulting from inappropriate antibody use in food animals is pregnant, equally pathogenic-resistant organisms propagated in these livestock are poised to enter the food supply and could exist widely disseminated in food products.10 – 15 Commensal bacteria plant in livestock are frequently present in fresh meat products and may serve equally reservoirs for resistant genes that could potentially exist transferred to pathogenic organisms in humans.16 , 17
While antibiotic use in food animals may correspond a risk to human health, the degree and relative impact have not been well characterized. Given divergent stakeholder interests and inadequate research to date, public policy discussions of this issue are often contentious and highly polarized. The aim of this review is to examine the telescopic and nature of antibiotic use in nutrient animals and summarize its potential bear upon on human health. We also review key national and international policies on utilise of antibiotics in nutrient animals. Finally, nosotros propose future directions for research and monitoring of the agricultural use of antibiotics.
METHODS
We searched three online databases of medical and scientific literature citations—the National Library of Medicine's MEDLINE®, the U.S. Department of Agriculture's National Agricultural Library Itemize (known as AGRICOLA), and Thomson Reuter's Web of Scientific discipline—for English-language documents from 1994–2009 containing the keywords "antibody," "antibiotic resistance," "antimicrobial," "antimicrobial resistance," "agriculture," "livestock," "food animal," "farm beast," "pig," "swine," "cattle," "cow," "poultry," and "chicken." Two authors reviewed the references and selected exemplary original research manufactures examining the association between antibiotic use in food animals and antibiotic-resistant bacteria in humans. We as well performed searches of the ROAR Commensal Literature Database (part of the Reservoirs of Antibiotic Resistance [ROAR] project, coordinated by the Alliance for Prudent Use of Antibiotics and funded by a grant from the National Institute of Allergy and Infectious Diseases) and the World Wellness Arrangement (WHO) website to identify research articles and policy documents pertaining to antibiotic use in food animals. An online search engine was used to locate policy statements published by governmental agencies.
RESULTS
In our review, we plant that the use of antibiotics in nutrient animals is widespread, yet poorly characterized. Furthermore, in existing studies, neither the risks to human health nor the benefits to animal product take been well studied. Nosotros also plant a lack of consistency in national and international policies.
In the following sections, we review the current literature on the nature and scope of antibiotic use in food animals, and on the epidemiologic links between use of antibiotics in food animals and resistance in humans. We and then provide an overview of the complex chance assay framework required to understand this problem. Finally, we review key national and international policy and regulatory recommendations.
Literature on the nature and telescopic of antibiotic use in food animals
The high population density of modern intensively managed livestock operations results in sharing of both commensal flora and pathogens, which tin be conducive to rapid dissemination of infectious agents. Every bit a result, livestock in these environments commonly require aggressive infection management strategies, which often include the employ of antibiotic therapy.
Antibiotics are used in food animals to treat clinical affliction, to preclude and control common disease events, and to heighten animal growth.eighteen The dissimilar applications of antibiotics in food animals have been described as therapeutic use, prophylactic use, and subtherapeutic utilise. Antibiotics can exist used to treat a single animal with clinical disease or a large group of animals. However, these various uses are oft indistinct; definitions of each blazon of utilize vary, and the approaches are often applied concurrently in livestock populations.19 For case, 16% of all lactating dairy cows in the U.S. receive antibiotic therapy for clinical mastitis each year, but nearly all dairy cows receive intramammary infusions of safe doses of antibiotics following each lactation to prevent and control future mastitis—primarily with penicillins, cephalosporins, or other beta-lactam drugs.twenty Similarly, 15% of beef calves that enter feedlots receive antibiotics for the treatment of clinical respiratory affliction, but therapeutic antibiotic doses are as well administered to 10% of apparently healthy calves to mitigate predictable outbreaks of respiratory affliction.21 Forty-ii per centum of beef calves in feedlots are fed tylosin—a veterinarian macrolide drug—to preclude liver abscesses that negatively impact growth, and approximately 88% of growing swine in the U.S. receive antibiotics in their feed for disease prevention and growth promotion purposes, commonly tetracyclines or tylosin.22 Nigh antibiotic apply in livestock requires a veterinary prescription, although individual treatment decisions are often made and administered by lay farm workers in accordance with guidelines provided by a veterinary.23 , 24
Despite the widespread adoption of antibiotic use in nutrient animals, reliable data about the quantity and patterns of use (e.1000., dose and frequency) are non available.25 Quantifying antibiotic utilize in nutrient animals is challenging due to variations in study objectives—investigators may measure merely therapeutic uses, only nontherapeutic uses, or a combination thereof, depending on their outcome of interest—and lack of clarity surrounding the definitions of therapeutic vs. nontherapeutic uses.26 Although limited, the available data suggest that nutrient animal production is responsible for a significant proportion of antibiotic utilize. In 1989, the Institute of Medicine estimated that approximately half of the 31.nine million pounds of antimicrobials consumed in the U.S. were for nontherapeutic use in animals.27 More recent estimates by the Union of Concerned Scientists, an advocacy group that supports reduced agricultural antimicrobial employ, suggest that 24.6 million pounds of antimicrobials are used for nontherapeutic purposes in chickens, cattle, and swine, compared with merely 3.0 1000000 pounds used for human being medicine. Calculations past the pharmaceutical industry-sponsored Animal Wellness Institute are more conservative, suggesting that of 17.8 million pounds of antimicrobials used for animals, only 3.1 meg pounds are used nontherapeutically.26 Twelve classes of antimicrobials—arsenicals, polypeptides, glycolipids, tetracyclines, elfamycins, macrolides, lincosamides, polyethers, beta-lactams, quinoxalines, streptogramins, and sulfonamides—may be used at different times in the life bicycle of poultry, cattle, and swine.25 While some of the antimicrobials used in animals are not currently used to treat human disease, many, such as tetracyclines, penicillins, and sulfonamides, are too used in the treatment of infections in humans.26 The WHO has developed criteria for the nomenclature of antibiotics equally "critically important," "highly of import," and "important" based on their importance in the treatment of man disease.28 , 29
Withal, other classes of antimicrobials used in agriculture have not led to concerns nearly dissemination of resistance in humans. For example, some of the most oftentimes used antibiotics in ruminants are ionophores, a distinctive class of antibiotics that alter intestinal flora to achieve increased energy and amino acid availability and improved nutrient utilization. Most beef calves in feedlots and some dairy heifers receive this drug routinely in their feed. Because of their specific style of action, ionophores have never been used in humans or therapeutically in animals. While some bacteria are intrinsically resistant to these drugs, there is currently no show to propose that ionophore resistance is transferable or that co-pick for resistance to other classes of antimicrobials occurs.xxx
Literature suggesting epidemiologic evidence of an association between antibody apply in food animals and antibiotic resistance in humans
Evidence that antibiotic use in nutrient animals tin result in antibody-resistant infections in humans has existed for several decades. Associations betwixt antibiotic utilise in nutrient animals and the prevalence of antibiotic-resistant leaner isolated from those animals take been detected in observational studies also equally in randomized trials. Antibiotic-resistant bacteria of animal origin have been observed in the environs surrounding livestock farming operations, on meat products available for buy in retail food stores, and every bit the cause of clinical infections and subclinical colonization in humans. Figure 1 outlines a sampling of prevalence studies, outbreak investigations, ecological studies, case-control studies, and randomized trials whose results suggest a potential relationship between antibiotic use in food animals and antibiotic resistance in humans.
Literature on the risks and benefits of antibody utilise in food animals
To understand how antibody use in agronomics might bear upon the emergence of antibody resistance, it is essential to consider the complex interaction of elements in the physical environment (e.yard., air, soil, and h2o) with social exchanges (e.g., betwixt animals within a herd, farmers and animals, and domestic poultry and migratory birds), in processing steps (e.1000., farming activities, transportation, and storage), and in homo use patterns (e.m., food grooming, meat consumption, and susceptibility to infection) (Effigy 2). Antibiotic use in animals can have direct and indirect furnishings on human health: direct effects are those that can be causally linked to contact with antibiotic-resistant leaner from nutrient animals, and indirect effects are those that effect from contact with resistant organisms that have been spread to various components of the ecosystem (e.thousand., h2o and soil) as a consequence of antibiotic employ in food animals (Figure 3).
Effigy 3.
Examples of direct and indirect effects of antibiotic use in nutrient animals on human health
Given the multitude of factors that contribute to the pathways past which antibiotic use in nutrient animals could pose risks to homo health, it is not surprising that a wide variety of methods has been used by researchers in various disciplines to arroyo the trouble. In full general, risk assessment models in veterinarian medicine emphasize beast health and handling of diseases in animals, food scientists' studies focus on the condom of man food supplies and the presence of antibiotic-resistant bacteria on food products, clinicians and epidemiologists investigate human outbreaks caused by resistant infections for which animals are identified as primary sources, and molecular biologists examine relationships between resistant strains and the prevalence of specific resistance genes in human and animate being bacteria. It is unlikely that any unmarried study volition be able to fully and accurately quantify the relationship betwixt antibody use in food animals and infections in humans. At all-time, just crude estimates of the etiologic fraction or "touch fraction" tin exist made for specific links in the ecologic chain.31
Several mathematical models have been proposed to quantify the overall risk associated with antibiotic utilize in animals, typically by estimating the prevalence of infection with a specific organism and its associated morbidity, and and so multiplying by the proportion of these infections believed to be attributable to antibiotic use in food animals. While models of this nature have been rightfully criticized for failing to include indirect risk and, consequently, underestimating total potential risk, felicitous risk cess strategies must also consider the potential benefits of antibiotic apply in food animals. Even though agronomical antibody utilise carries a demonstrated risk, there are likely benefits to the agricultural use of antibiotics also. For example, reducing animal microbial load and shedding could lead to safer, more affordable food. However, many of the claims of benefit have not been fully demonstrated in large-scale trials, and other trials have shown that the overall touch on of the short-term benefit is poorly described.
The U.S. Nutrient and Drug Administration (FDA) requires manufacturers of new antibiotics to perform risk assessments to demonstrate that new drugs are safety and constructive for use in animals and that "there is reasonable certainty of no damage to human being health from the proposed use of the drug in food-producing animals."32 To evaluate potential man health consequences, the FDA employs a qualitative framework to classify as "low," "medium," or "high" the probabilities that leaner in the animal population will acquire resistance, that humans will ingest the resistant bacteria in food products, and that ingesting the bacteria will result in agin health outcomes (Figure four). Drug approval decisions are based on these hazard estimations, along with information about proposed marketing status (e.k., prescription, over-the-counter, or veterinary feed additives), extent of limitations on extra-label use, and intended use patterns (e.yard., duration of use and assistants to individual animals vs. select groups of animals vs. flocks or herds of animals). "Loftier-risk" drugs may exist approved if the FDA determines that human health risk can be mitigated. "Medium-chance" drugs could be approved if appropriate label restrictions are required.
In improver to the direct risk assessment model, the FDA has developed guidance to determine the risk of antibiotic residues remaining on food products.32 This guidance recommends determining the impact of antibiotic residues on normal man abdominal flora and the presence of resistance in these strains, and it provides guidelines for the calculation of Adequate Daily Intake (ADI) for antibiotic residues that pose an appreciable hazard to human wellness.
Guidelines and recommendations on the use of antibiotics in food animals
Given the importance of antibody resistance every bit a public health trouble, many governments and professional societies have reviewed existing scientific testify and developed recommendations to limit all types of antibiotic use, including utilise in food animals. Depending on the nature and jurisdiction of each grouping, the findings may provide best practice guidelines for antibody employ, prioritized agendas for research on the emergence of antibiotic resistance, recommendations for legislative activeness to regulate drug approval and surveillance processes, or enforceable laws on the manufacture, distribution, and prescription of antibiotics. Figure 5 summarizes recommendations straight related to utilise of antibiotics in nutrient animal production for a sample of national and international guidance and policy documents.
DISCUSSION
Despite increasingly widespread recognition that antibiotic use in nutrient animals is an important contributor to man infections with antibiotic-resistant bacteria (Figure 1), in that location remains a significant need for scientific testify of the antibiotic use practices that create the greatest man wellness gamble. Our goal with this article was not to propose specific solutions to the trouble—in office because we believe there are no like shooting fish in a barrel, specific answers—just rather to reiterate and summarize the importance of this outcome and to advise some full general policy directions that are indicated. Equally the importance of the problem and complexity of the issues are increasingly appreciated by the public, policy dialogue, focused research, and informed regulatory activeness can exist undertaken. To facilitate farther research and timely action in response to emerging knowledge on this issue, we propose the following measures, which are in concert with WHO's global strategy for the containment of antimicrobial resistance, the U.S. Interagency Task Force on Antibiotic Resistance's public wellness activity plan to combat antimicrobial resistance, and the Infectious Diseases Society of America's call to action.33 – 35
Develop a scientific agenda to recommend appropriate report designs and specific aims related to antimicrobial use in food animals
A coordinated plan is needed to identify missing scientific information and to specify research designs and methods to address these needs. Although rigorous studies have been conducted in some disciplines, there has been a lack of serious and harmonized interdisciplinary try to expand on the corpus of knowledge, which should exist used to inform public policy. To result in a useful and consummate list of research priorities, the agenda must include contributions by experts in basic sciences (east.chiliad., genetics and microbiology), clinical sciences (east.g., veterinary medicine and human medicine), public health (e.k., epidemiology and nursing), social sciences (e.yard., anthropology and sociology), economic science (east.g., health and agriculture), and public policy (e.g., legislative and regulatory). Research goals put forth in the agenda should be reflective of methodological weaknesses identified in the existing literature. For example, definitions of antibiotic uses in food animals (east.g., therapeutic and subtherapeutic) should be standardized and designed to reflect specific goals (e.chiliad., improving production or preventing economical loss from unrestrained disease); the terms should be recognized beyond disciplines and used to allocate the potential effects of different types of antibiotic use on human wellness. Some other potential focus could be whether to arroyo research on the development of resistance narrowly (i.due east., the causes and effects of specific drug-organism combinations) or broadly (i.eastward., the causes and furnishings of all antibiotics used in animals on microbial flora) to develop public wellness recommendations.
Fund agricultural research that reflects the priorities identified by the inquiry agenda
Inadequate funding for agricultural inquiry has likely contributed to the lack of sufficient scientific bear witness necessary for informing public health decisions. For example, in the United States, it was recently estimated that the $101 billion in combined governmental and biomedical manufacture research funding represents nigh 5% of national health expenditures each yr.36 In 2007, the U.S. Department of Agriculture provided more than $32 million in external enquiry funding, representing less than one one-thousandth of 1% of almanac U.Southward. livestock and poultry sales.37 In contrast, one unmarried Institute within the National Institutes of Health—the National Establish of Allergy and Infectious Diseases—directed more than 20 times this amount to antimicrobial resistance research (more $800 million) in the same year.38 Given the scale of the antibody resistance problem and the demonstrated function of agricultural antibiotic uses in this impending public health crunch, adequate support for inquiry specific to the role of agricultural uses of antibiotics in the development of resistance must be a national priority. Considering that the U.Due south. funds 70% to fourscore% of biomedical enquiry worldwide, the demand for appropriate levels of funding is especially acute.36
Urgently address barriers to the collection and assay of antimicrobial use information
Complex political, economic, and social barriers limit the quality of data on the use of antibiotics in nutrient animals. Currently, such information are provided on a voluntary ground, and the methods used to collect and compile reports are not standardized or fully transparent. While voluntary industry compliance with antibody reporting is commendable, the long-term effectiveness of nonbinding auditing programs is unproven. Effective surveillance of veterinary antimicrobial production and administration to food animals is a key get-go stride toward ascertaining realistic estimates of the full telescopic of antibiotic use. These data will be useless, notwithstanding, unless an agency with adequate analytic, regulatory, and enforcement capabilities exists. Because the commercial interests of antibiotic manufacturers must be appropriately balanced with the public health urgency for development of new antibiotics, any agency tasked with monitoring antibiotic resistance must operate independently of commercial influences when releasing data to the public and drafting testify-based regulations to safeguard human wellness.
CONCLUSION
It is evident that now, the resources devoted to studying the office of antibiotic use in food animals—both in terms of funding and scientific inquiry—are insufficient. It is now disquisitional that agronomical apply of antibiotics be recognized as one of the major contributors to the development of resistant organisms that result in life-threatening human infections and included every bit part of the strategy to control the mounting public health crisis of antibody resistance.
Footnotes
During portions of this project, Dr. Landers was supported by a training grant from the National Constitute of Nursing Research, National Institutes of Wellness (Training in Interdisciplinary Research to Reduce Antimicrobial Resistance; T90 NR010824).
REFERENCES
1. Boyce JM. Customs-associated methicillin-resistant Staphylococcus aureus as a cause of health intendance-associated infection. Clin Infect Dis. 2008;46:795–8. [PubMed] [Google Scholar]
2. Popovich KJ, Weinstein RA. The graying of methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol. 2009;xxx:9–12. [PubMed] [Google Scholar]
3. Aminov RI, Mackie RI. Evolution and ecology of antibiotic resistance genes. FEMS Microbiol Lett. 2007;271:147–61. [PubMed] [Google Scholar]
four. Courvalin P. Predictable and unpredictable evolution of antibody resistance. J Intern Med. 2008;264:4–xvi. [PubMed] [Google Scholar]
five. Spellberg B, Powers JH, Brass EP, Miller LG, Edwards JE., Jr Trends in antimicrobial drug development: implications for the future. Clin Infect Dis. 2004;38:1279–86. [PubMed] [Google Scholar]
half-dozen. Talbot GH, Bradley J, Edwards JE, Jr, Gilbert D, Scheld M, Bartlett JG. Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Chore Forcefulness of the Infectious Diseases Guild of America. Clin Infect Dis. 2006;42:657–68. [PubMed] [Google Scholar]
7. Norrby SR, Nord CE, Finch R European Social club of Clinical Microbiology and Infectious Diseases. Lack of development of new antimicrobial drugs: a potential serious threat to public health. Lancet Infect Dis. 2005;5:115–9. [PubMed] [Google Scholar]
8. Avorn JL, Barrett JF, Davey PG, McEwen SA, O'Brien TF, Levy SB. Geneva: World Health Arrangement; 2001. [cited 2010 Nov x]. Antibiotic resistance: synthesis of recommendations by adept policy groups. Also available from: URL: http://whqlibdoc.who.int/hq/2001/WHO_CDS_CSR_DRS_2001.ten.pdf. [Google Scholar]
9. Belongia EA, Knobloch MJ, Kieke BA, Davis JP, Janette C, Besser RE. Impact of statewide programme to promote advisable antimicrobial drug use. Emerg Infect Dis. 2005;11:912–20. [PMC gratis article] [PubMed] [Google Scholar]
10. Garofalo C, Vignaroli C, Zandri M, Aquilanti L, Bordoni D, Osimani A, et al. Direct detection of antibody resistance genes in specimens of chicken and pork meat. Int J Food Microbiol. 2007;113:75–83. [PubMed] [Google Scholar]
11. Cui South, Ge B, Zheng J, Meng J. Prevalence and antimicrobial resistance of Campylobacter spp. and Salmonella serovars in organic chickens from Maryland retail stores. Appl Environ Microbiol. 2005;71:4108–11. [PMC free commodity] [PubMed] [Google Scholar]
12. Gundogan Due north, Citak S, Yucel N, Devren A. A note on the incidence and antibiotic resistance of Staphylococcus aureus isolated from meat and chicken samples. Meat Sci. 2005;69:807–10. [PubMed] [Google Scholar]
13. Kim SH, Wei CI, Tzou YM, An H. Multidrug-resistant Klebsiella pneumoniae isolated from subcontract environments and retail products in Oklahoma. J Food Prot. 2005;68:2022–ix. [PubMed] [Google Scholar]
14. Parveen S, Taabodi M, Schwarz JG, Oscar TP, Harter-Dennis J, White DG. Prevalence and antimicrobial resistance of Salmonella recovered from processed poultry. J Food Prot. 2007;lxx:2466–72. [PubMed] [Google Scholar]
15. Ramchandani M, Manges AR, DebRoy C, Smith SP, Johnson JR, Riley LW. Possible brute origin of homo-associated multidrug-resistant, uropathogenic Escherichia coli. Clin Infect Dis. 2005;40:251–7. [PubMed] [Google Scholar]
16. Mena C, Rodrigues D, Silva J, Gibbs P, Teixeira P. Occurrence, identification, and characterization of Campylobacter species isolated from Portuguese poultry samples collected from retail establishments. Poult Sci. 2008;87:187–90. [PubMed] [Google Scholar]
17. Diarrassouba F, Diarra MS, Bach S, Delaquis P, Pritchard J, Topp E, et al. Antibiotic resistance and virulence genes in commensal Escherichia coli and Salmonella isolates from commercial broiler chicken farms. J Food Prot. 2007;70:1316–27. [PubMed] [Google Scholar]
eighteen. McEwen SA, Fedorka-Cray PJ. Antimicrobial use and resistance in animals. Clin Infect Dis. 2002;34(Suppl 3):S93–106. [PubMed] [Google Scholar]
19. Institute of Medicine; National Research Council; Panel on Animal Wellness, Nutrient Safety and Public Wellness; Committee on Drug Use in Nutrient Animals. Washington: National Academy Press; 1999. The apply of drugs in nutrient animals: benefits and risks. [Google Scholar]
20. Section of Agriculture (US) Fort Collins (CO): USDA, Animal and Plant Wellness Inspection Service, Veterinary Services, National Animal Health Monitoring Arrangement; 2008. Sep, [cited 2010 Nov 11]. Dairy 2007 office III: reference of dairy cattle health and management practices in the United States, 2007. As well available from: URL: http://www.aphis.usda.gov/animal_health/nahms/dairy/downloads/dairy07/Dairy07_dr_PartIII_rev.pdf. [Google Scholar]
22. Department of Agriculture (US) Fort Collins (CO): USDA, Animal and Constitute Wellness Inspection Service, Veterinary Services, National Animal Health Monitoring System; 2008. Mar, [cited 2011 Sep 12]. Swine 2006 part III: reference of swine health, productivity, and general management in the United States, 2006. Also bachelor from: URL: http://world wide web.aphis.usda.gov/animal_health/nahms/swine/downloads/swine2006/Swine2006_dr_PartIII.pdf. [Google Scholar]
23. Raymond MJ, Wohrle RD, Phone call DR. Cess and promotion of judicious antibiotic use on dairy farms in Washington State. J Dairy Sci. 2006;89:3228–40. [PubMed] [Google Scholar]
24. Sawant AA, Sordillo LM, Jayaro BM. A survey on antibiotic usage in dairy herds in Pennsylvania. J Dairy Sci. 2005;88:2991–9. [PubMed] [Google Scholar]
25. Sarmah AK, Meyer MT, Boxall AB. A global perspective on the use, sales, exposure pathways, occurrence, fate and effects of veterinary antibiotics (VAs) in the surroundings. Chemosphere. 2006;65:725–59. [PubMed] [Google Scholar]
27. Institute of Medicine. Washington: National Academy Press; 1989. Human wellness risks with the subtherapeutic apply of penicillin or tetracyclines in animal feed. [Google Scholar]
28. World Health System. Critically important antimicrobials for human medicine: categorization for the development of run a risk management strategies to incorporate antimicrobial resistance due to non-man antimicrobial use. Report of the Second WHO Proficient Meeting; 29-31 May 2007; Copenhagen. [cited 2010 Nov 11]. Available from: URL: http://www.who.int/foodborne_disease/resistance/antimicrobials_human.pdf. [Google Scholar]
29. Collingnon P, Powers JH, Chiller TM, Aidara-Kane A, Aarestrup FM. World Health Organization ranking of antimicrobials according to their importance in human being medicine: a critical footstep for developing risk management strategies for the use of antimicrobials in nutrient product animals. Clin Infec Dis. 2009;49:132–41. [PubMed] [Google Scholar]
thirty. Callaway TR, Edrington TS, Rychlik JL, Genovese KJ, Poole TL, Jung YS, et al. Ionophores: their employ equally ruminant growth promotants and impact on nutrient safety. Curr Problems Intest Microbiol. 2003;4:43–51. [PubMed] [Google Scholar]
31. Greenland S, Rothman KJ, Lash TL. Measures of upshot and measures of association. In: Rothman KJ, Greenland S, Lash TL, editors. Modernistic epidemiology. 3rd ed. Philadelphia: Wolters Kluwer/ Lippincott Williams & Wilkins; 2008. pp. 51–70. [Google Scholar]
32. Department of Health and Human Services (US), Nutrient and Drug Administration, Center for Veterinary Medicine. Guidance for industry #152: evaluating the safe of antimicrobial new animal drugs with regard to their microbiological effects on bacteria of human health business organisation. 2003. October 23, [cited 2010 Nov eleven]. Available from: URL: http://www.fda.gov/downloads/AnimalVeterinary/-GuidanceComplianceEnforcement/GuidanceforIndustry/UCM052519.pdf.
33. Earth Health Organisation. WHO global principles for the containment of antimicrobial resistance in animals intended for nutrient: report of a WHO consultation with the participation of the Food and Agriculture Organization of the United nations and the Office International des Epizooties, 5–nine Jun 2000, Geneva. [cited 2010 November 11]. Bachelor from: URL: http://whqlibdoc.who.int/hq/2000/who_cds_csr_aph_2000.4.pdf.
34. Interagency Task Force on Antimicrobial Resistance (The states) Atlanta: Centers for Disease Control and Prevention (U.s.), Food and Drug Administration (United states), National Institutes of Health; 2008. Jun, [cited 2010 Nov 11]. A public health action plan to combat antimicrobial resistance: role 1: domestic problems. Also available from: URL: http://www.cdc.gov/drugresistance/actionplan/aractionplan.pdf. [Google Scholar]
35. Spellberg B, Guidos R, Gilbert D, Bradley J, Boucher HW, Scheld WM, et al. The epidemic of antibiotic-resistant infections: a telephone call to action for the medical community from the Infectious Diseases Club of America. Clin Infect Dis. 2008;46:155–64. [PubMed] [Google Scholar]
36. Dorsey ER, de Roulet J, Thompson JP, Reminick JI, Thai A, White-Stellato Z, et al. Funding of Usa biomedical research, 2003–2008. JAMA. 2010;303:137–43. [PMC free article] [PubMed] [Google Scholar]
37. Roberts RM, Smith GW, Bazer FW, Cibelli J, Seidel GE, Jr, Bauman DE, et al. Inquiry priorities: farm animal research in crunch. Scientific discipline. 2009;324:468–9. [PubMed] [Google Scholar]
38. Peters NK, Dixon DM, The netherlands SM, Fauci AS. The research agenda of the National Found of Allergy and Infectious Diseases for antimicrobial resistance. J Infect Dis. 2008;197:1087–93. [PubMed] [Google Scholar]
Articles from Public Health Reports are provided here courtesy of SAGE Publications
Source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3234384/
Posted by: jacksonbabinfor.blogspot.com
0 Response to "What Percent Of Antibiotics Are Given To Animals Fda"
Post a Comment